Compare Gilead Sciences, Inc. (GILD) vs Kroger Co (KR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gilead Sciences, Inc. vs Kroger Co — how do they compare? Gilead Sciences, Inc. trades at $133.19 (market cap $163.51B), while Kroger Co trades at $57.14 (market cap $34.65B). The key difference: Gilead Sciences, Inc. is far larger — about 4.7× Kroger Co's market cap, and Gilead Sciences, Inc. pays the higher dividend (2.49%). Which is the better fit depends on your goals.
| GILD | KR | |
|---|---|---|
Market Cap | $163.51B | $34.65B |
Sector | Health | Consumer Staples |
52-Week High | $155.80 | $75.60 |
52-Week Low | $108.22 | $55.53 |
Enterprise Value | $178.05B | $54.75B |
Dividend Yield | 2.49% | 2.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gilead Sciences (GILD) trades at $130.04, down 1.04% on the day, with technical indicators showing a bearish bias while fundamentals remain strong. The company has beaten earnings expectations for three consecutive quarters, maintains robust profitability with a 30.99% net income margin, and recently secured FDA and European Commission approvals for expanded use of its oncology drug Trodelvy. Analyst consensus remains overwhelmingly positive with a $152.83 price target representing 17.5% upside potential.
The outlook for GILD is favorable with strong earnings momentum, expanding oncology portfolio, and solid cash generation, though risks include patent expirations, competitive pressures in HIV treatments, and recent negative cash flow trends. The stock presents a compelling opportunity for investors seeking exposure to a profitable biopharmaceutical company with growth catalysts, supported by Wall Street's bullish sentiment and recent regulatory wins.
Kroger (KR) trades at $58.74, down 0.96% today, with a bearish technical outlook despite recent earnings beats. The company maintains stable revenue around $147B with improving net margins to 1.81% in 2025. Recent acquisition of Giant Eagle for $1.65 billion expands Midwest presence, while Berkshire Hathaway ownership provides institutional confidence. Valuation shows mixed signals with low P/S of 0.28 but elevated P/E of 55.29.
KR offers defensive exposure with dividend yield support, but faces competitive grocery wars and margin pressure. Analyst consensus targets $68.63 (17% upside) with 48% buy ratings. Key risks include integration execution of Giant Eagle deal and industry pricing pressures. Cash flow strength supports dividend sustainability despite negative ROE.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →About Kroger Co
Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.
Read more on KR →
